3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Unknown
2
Terminated
2
Recruiting
2
Completed
2
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
92
Breast Neoplasms
85
Neoplasms
79
Prostatic Neoplasms
50
Lung Neoplasms
43
Neoplasm Metastasis
40
Colorectal Neoplasms
37
Leukemia, Myeloid, Acute
32
Pain
27
Head and Neck Neoplasms
25
Colonic Neoplasms
25
Multiple Myeloma
24
Ovarian Neoplasms
23
Lymphoma
23
Carcinoma, Hepatocellular
23
Pancreatic Neoplasms
22
Lymphoma, Follicular
21
Melanoma
20
Leukemia
20
Rectal Neoplasms
19
Lymphoma, Non-Hodgkin
19
Urinary Bladder Neoplasms
17
Recurrence
17
Stomach Neoplasms
15
Lymphoma, Large B-Cell, Diffuse
15
Leukemia, Lymphocytic, Chronic, B-Cell
15
Squamous Cell Carcinoma of Head and Neck
13
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Leiomyoma
13
Brain Neoplasms
13
Interventions
Oxaliplatin
1
Mitomycin
1
Gemcitabine
1
Ethiodized Oil
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Terminated
×
Neoplasm Recurrence, Local
×
Clear all
NCT01200992
2017-08-24
EMBARC-RF
Bioniche Life Sciences Inc.
Phase 3
Terminated
84 enrolled
7 charts
NCT00470340
2011-05-05
GEMOXIAL
Assistance Publique - Hôpitaux de Paris
Phase 3
Terminated
263 enrolled